Skip to main content

Advertisement

Table 3 The serial change in mean value (SD) of IPSS and OABSS

From: Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil -

Variable Baseline 1 month 3 months 6 months 12 months
IPSS (total)
Naftopidil (n=70) 6.8 (4.3) 15.5** (8.0) 17.4** (8.5) 13.5** (7.9) 9.8** (7.1)
Silodosin (n=71) 7.9 (5.5) 15.5** (9.5) 18.3** (9.1) 14.4** (7.9) 9.8** (7.2)
Total (n=141) 7.4 (5.0) 15.5** (8.7) 17.8** (8.8) 13.9** (7.9) 9.8** (7.1)
OABSS (total)
Naftopidil (n=70) 3.5 (2.2) 6.1** (3.4) 6.8** (3.8) 5.8** (3.2) 4.5** (3.0)
Silodosin (n=71) 3.4 (2.6) 6.2** (3.7) 6.4** (3.5) 5.2** (3.2) 4.0** (3.0)
Total (n=141) 3.4 (2.4) 6.2** (3.6) 6.6** (3.6) 5.5** (3.2) 4.3** (3.0)
  1. Baseline vs. *p < 0.05, **p < 0.01.